SPRY2 and viral infectious disease: Furthermore, we demonstrate that Spry2-deficient DCs retain an unaltered ability to stimulate CD8<sup>+</sup> T-cell activation and proliferation, ultimately resulting in normal CD8<sup>+</sup> T-cell effector differentiation during acute viral infection.